Patent Assignment
Reel/Frame 062905/0112
Assignment of Assignor's Interest
Recorded: 2023-03-07
Pages: 8
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(4)
Heteroaromatic Nmda Receptor Modulators and Uses Thereof
Heteroaromatic Nmda Receptor Modulators and Uses Thereof
Heteroaromatic Nmda Receptor Modulators and Uses Thereof
Heteroaromatic Nmda Receptor Modulators and Uses Thereof
Application:
62/265,182 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 10, 2016
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: LUC THERAPEUTICS
Reel/Frame 037946/0274 →
Assignment of Assignor's Interest
Dec 21, 2018
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 047842/0043 →
Assignment of Assignor's Interest
Apr 27, 2020
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 052504/0619 →
Change of Name
Jun 8, 2020
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 052873/0347 →
Assignment of Assignor's Interest
Jul 27, 2022
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 060641/0439 →